Gilead Sciences (GILD)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Gilead Sciences | GILD | Healthcare | Drug Manufacturers - General | 44 | 6.5% |
Current Price ( 5/26 4:00PM EDT) | $77.09 | |||
CAPS Rating (Rate this stock on CAPS) | ![]() |
|||
Expected Income Statement | ||||
Current Sales | 27,043.0 | |||
Sales Growth Forecast | 0.5% | |||
Net Profit Margin | 27.6% | |||
Projected Shares Outstanding | 1,234.96 | |||
EPS - Five year Forecast | $6.20 | |||
Average P/E Ratio | 14.0 | |||
Projected Average Price | $86.81 | |||
Price Appreciation (Annualized) | 2.4% | |||
Annual Dividend Yield | 4.1% | |||
Projected Annual Return | 6.5% | |||
Quality | ||||
Financial Strength | 46 | 11.5 | ||
EPS Stability | 46 | 11.6 | ||
Industry Sales Growth Rate | 4.0% | 1.6 | ||
Industry Net Profit Margin | 19.3% | 17.9 | ||
Calculated Quality Rating | 42.6 | |||
Fool CAPS | ||||
Total Players
3341
Outperforms
90
Underperforms
All-Stars (624)
613
Outperforms (98%)
11
Underperforms
|
||||
Fundamental Data Updated: 04/28/2023 |